Table III.

Clinical characteristics of 72 human epidermal growth factor receptor-positive patients and the expression of serum exosomal SNHG14.

Factors	No. of cases	Serum exosomal lncRNA SNHG14 (2−∆∆Cq; median ± interquartile range)	P-value
Age, years			0.887
<50	43	4.32 (1.24–7.55)
≥50	29	4.57 (1.45–7.50)
Tumor size			0.026
<6 cm	31	3.75 (1.24–6.66)
≥6 cm	41	4.64 (1.66–8.17)
Weight loss			0.154
<3 kg	42	3.98 (2.07–6.66)
≥3 kg	30	4.15 (1.69–8.65)
Histological grade			0.037
Well differentiated	16	3.77 (2.12–6.36)
Moderately differentiated	38	4.06 (2.07–7.45)
Poorly differentiated	18	4.37 (2.78–8.65)
Lymph node metastasis			0.002
No	16	3.36 (0.29–7.38)
Yes	56	4.37 (2.07–8.65)
Distant metastasis			0.000
No	40	3.77 (1.55–7.46)
Yes	32	4.88 (1.69–8.65)
Cardiac toxicity			0.006
Yes	25	4.82 (1.08–7.94)
No	47	3.95 (1.37–6.78)

lncRNA, long non-coding RNA; SNHG14, small nucleolar RNAhost gene 14.